Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to 0.15%.

  • Integra Lifesciences Holdings' Return on Capital Employed fell 1600.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.01% for FY2024, which is 200.0% down from last year.
  • Integra Lifesciences Holdings' Return on Capital Employed amounted to 0.15% in Q3 2025, which was down 1600.0% from 0.17% recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Return on Capital Employed registered a high of 0.07% during Q4 2022, and its lowest value of 0.17% during Q2 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.05% (2021), whereas its average is 0.02%.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Return on Capital Employed surged by 400bps in 2021 and then plummeted by -1900bps in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Return on Capital Employed stood at 0.06% in 2021, then increased by 18bps to 0.07% in 2022, then tumbled by -52bps to 0.03% in 2023, then plummeted by -72bps to 0.01% in 2024, then crashed by -1708bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.17% for Q2 2025, and 0.0% during Q1 2025.